During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and ...
Investigators at the Jacobs School have uncovered how heat causes a critical receptor protein within cells to unfold and relay pain, which could open up new therapeutic targets for treating pain.
Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...
MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...
One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...
Mal-ID – can decipher an individual’s immune system’s record of past infections and diseases, according to a new study, providing a powerful tool with the potential for diagnosing autoimmune disorders ...
Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...
Recent advances in the field of immunology suggest that innate immune cells (e.g. dendritic cells, NK cells, phagocytes) are capable of displaying a form of ...
A team of researchers from the Indian Institute of Science shows that tweaking the spacing between the cells’ binding domain ...
Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...
Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback